SCHEMBL14970401

SCHEMBL14970401

CC(=O)N1CCc2oncc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.50
ENPP2 Q13822 1/20 0.38
MAPK1 P28482 1/20 0.36
SHMT2 P34897 1/20 0.36
SYK P43405 1/20 0.36
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
KCNH2 Q12809 1/20 0.35
TSHR P16473 1/20 0.35
PTAFR P25105 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
BAZ2B Q9UIF8 1/20 0.35
CREBBP Q92793 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20424296 0.85 MEN1 (0.35) NOTUMMAPK1SYKTSHRMEN1
SCHEMBL19722806 0.84 SYK (0.35) NOTUMMAPK1SYKTSHRMEN1
SCHEMBL16219041 0.83 JAK2 (0.41) SYKNAMPT
SCHEMBL15492432 0.83 HPGDS (0.43) MAPK1SYKPTAFRMEN1KMT2A
SCHEMBL13194712 0.80 RYR2 (0.36) SYKTSHRMEN1KMT2ANPC1
SCHEMBL15490051 0.80 NAMPT (0.40) MEN1KMT2ANPC1RAB9ANAMPT
SCHEMBL9944481 0.80 FNTA (0.37) SYKMEN1KMT2ANAMPT
SCHEMBL2584773 0.75 HPGD (0.51) GABRA5LMNANAMPT
SCHEMBL2580863 0.75 ALDH1A1 (0.55) MAPK1TSHRMEN1KMT2ALMNA
SCHEMBL2588873 0.75 ADORA2A (0.42) MAPTNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780337-B1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME (US) 2017-12-20 EP disclosed
US-9018224-B2 Substituted cyclopropyl compounds useful as GPR119 agonists MERCK SHARP & DOHME CORP. (US) 2015-04-28 US disclosed
US-20140329798-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME LLC 2014-11-06 US disclosed
WO-2013074388-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME CORP. (US) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329798-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS GPR119, GPR27, GCGR NOTUM 3650/4885ENPP2 369/4885MAPK1 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.